SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 41 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $141,980 | +23.5% | 142,000 | +21.4% | 0.06% | +34.0% |
Q4 2022 | $114,952 | +1.7% | 117,000 | 0.0% | 0.05% | -9.6% |
Q3 2022 | $113,000 | -0.9% | 117,000 | 0.0% | 0.05% | +18.2% |
Q2 2022 | $114,000 | -0.9% | 117,000 | 0.0% | 0.04% | +7.3% |
Q1 2022 | $115,000 | – | 117,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Radcliffe Capital Management, L.P. | 90,815,000 | $90,802,681 | 5.68% |
PIPER SANDLER & CO. | 6,695,000 | $6,694,063 | 4.58% |
Opti Capital Management, LP | 46,902,000 | $46,902,000 | 3.79% |
Monashee Investment Management LLC | 9,000,000 | $8,975,160 | 2.48% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 96,994,000 | $97,297,084 | 1.93% |
DeepCurrents Investment Group LLC | 41,092,000 | $40,966,177 | 1.60% |
Sonora Investment Management Group, LLC | 9,395,000 | $9,387,582 | 0.82% |
Penn Mutual Asset Management, LLC | 675,000 | $677,018 | 0.64% |
OAKTREE CAPITAL MANAGEMENT LP | 19,540,000 | $19,586,199 | 0.22% |
BRAIDWELL LP | 6,500,000 | $6,515,368 | 0.22% |